Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma release_4qwuls6gnvgvdc3kthjdkffwmi

by Afsaneh Bakshandeh-Bath, Anne S Stoltz, Nils Homann, Thomas Wagner, Stephanie Stölting, Stefan O Peters

Published in Anticancer Research.

2009   Volume 29, Issue 8, p3069-77

Abstract

Advanced pancreatic adenocarcinoma is usually treated with single-agent gemcitabine chemotherapy or combinations that include gemcitabine application that have palliative benefit but do not lead to survival benefits. We present the results of preclinical and clinical studies using combination chemotherapies that include 41.8 degrees C whole-body hyperthermia for pancreatic adenocarcinoma.
In text/plain format

Archived Files and Locations

application/pdf  122.5 kB
file_eihhwapuefhi3b6xfiom57xai4
www.lemmo.com (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   2009
Language   en ?
PubMed  19661318
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0250-7005
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 9f56eaab-35c0-4383-8efc-020bf5a9c3cc
API URL: JSON